AzTrials
AzTrials

Early Child Brain DevelopmentECD SB3NCT07472699

Enhancing the Ongoing ECD Scale-up Programme (Saving Bangladeshi Babies Brain (SB3) in Bangladesh

A study testing Psychosocial stimulation and Combined in people with Early Child Brain Development, run by International Centre for Diarrhoeal Disease Research, Bangladesh at 1 site in Bangladesh.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Background (brief): 1. Burden: Globally 250 million children under 5 years of age in developing countries do not reach their full potential due to poverty, malnutrition, and lack of a stimulating environment. 2. Read more about this study

Who is it for?
Ages 6 to 24 monthsHealthy volunteers can take part
Conditions the study is for
Early Child Brain Development
What is being tested?
Psychosocial stimulation and Combined
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,400 participants
Where
1 siteBangladesh
Study dates
1 Aug 2024to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 24 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Moderately and severely malnourished children aged 6-24 months of both sexes and whose parents agree to participate in the programme.
  • Mid-upper arm circumference (MUAC)<13.5cm will be used to define malnutrition
  • Maternal education qualification less than 8th grade
  • Monthly family income BDT<15000

Who cannot join

  • Children with MUAC≥13.5 cm
  • Those whose parents do not consent to participate

Trial locations and contacts

1 site in 1 country.

Bangladesh1 site
  • Icddr,B

    Dhaka

Other trials in Bangladesh

About this study

Official title: Extending and Enhancing the Ongoing Early Childhood Development (ECD) Scale-up Programme (Saving Bangladeshi Babies Brain (SB3) in Bangladesh

Background (brief):

  1. Burden: Globally 250 million children under 5 years of age in developing countries do not reach their full potential due to poverty, malnutrition, and lack of a stimulating environment.
  2. Knowledge gap: The early childhood intervention curriculum 'Reach up \& Learn' has been adapted for Bangladesh and were successfully used in 10 trials including two trials integrated with Primary Health Care (PHC) services implemented in Community Clinics. Based on the success of the last two studies, the current programme 'Saving Bangladeshi Babies Brains (SB3)' is conducted in 4 districts. Under this programme, a small cluster randomised controlled trial (cRCT) was conducted and found no benefit on child development. However, the programme involved implementation challanges. Therefore, there is a need to determine the strategies to mitigate the challenges and conduct another round of cRCT to test the effectiveness of the strategies on the child development outcomes.
  3. Relevance: Bangladesh Govt acknowledges the need for improving children's development and has agreed to collaborate and implement early childhood development (ECD) activities at large scale.
Read more

Hypothesis (if any): The Investigators hypothesize that the identified strategies would be effective in improving children's development.

Objectives:

  1. To identify the potential strategies to promote the quality and fidelity of the SB3 early childhood parenting programme integrated into government health care services.
  2. To measure the effectivity of the intervnetion on the cogntion, langauge, motor development, and beahvior of the children and maternal parenting knowledge and quality of stimulation at home.

Methods: A mixed-method data collection has been conducted and three potential strategies were identified: raising community awareness, increasing health worker's motivation to deliver a quality programme, and the revised curriculum by replacing mothers' made toys to the supplied toys from the progarmme. These startegies will be piloted. And based on the pilot findings, two strategies will be selected to test the effectiveness on child development using a cluster randomised controlled trial design. In the cluster RCT, there will be two arms : i) intervnetion arm I: regular curriclum, ii) intervnetion arm II: revised curriculum and iii) Unique control. Twenty unions from each programme running district will be randomly selected and then randomly allocated to intervention arm I \& II . A four non-programme running districts located at the border of the programme districts will be selected as unique control. The children will be tested at the beginning and the end of the 6 months of intervention.

Outcome measures/variables: The primary outcomes are children's cognition, and language development and the secondary outcomes are children's behaviour and growth, maternal knowledge on child care and their practices, home stimulation and maternal depressive symptoms.

Being tested
Psychosocial stimulation, Combined

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychosocial stimulationBehavioural

    Intervention Arm 1: Pschosocial stimulation intervention using toys made by the programme.

  • CombinedBehavioural

    Intervention Arm 2: Psychosocial stimulation intervnetion using toys made by mothers.

Study groups in NCT07472699
Study groupRoleWhat they receive
Intervention Arm 1: Stimulation intervnetionActive comparatorNot described
Receives: Behavioral: Psychosocial stimulation
Intervention Arm 2: New stimulation interventionExperimentalNot described
Receives: Behavioral: Combined
Unique controlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive development

    The primary outcomes are children's cognition, which will be assessed using the psychometric tool named "Bayley Scale of Infant and Toddler Development Version-IV'. The cognition scales include a series of developmental play tasks based on different abilities like memory, problem solving skill, number concepts, etc.

    Measured: From enrollment to the end of intervention after 6 months

  2. Language

    Children's language will be assessed using the psychometric tool named "Bayley Scale of Infant and Toddler Development Version-IV'. Language subscale contains two components: receptive and expressive test.

    Measured: From enriollment to after 6 months intervention.

Secondary outcomes (6)
  1. Children's Behavior

    Children's behavior will be assessed using the Wolke's Behavior Rating Scale during the cognitive and language assessment period.

    Measured: From enrollment to the end of intervention after 6 months

  2. Children's weight

    Weight measurement in Kg

    Measured: From enrollment to the end of intervention after 6 months

  3. Children's length

    Length in Cm

    Measured: From enrollment to the end of intervention after 6 months

  4. Home stimulation

    Children's home stimulation will be assessed using Family Care Indicator (FCI)

    Measured: From enrollment to the end of intervention after 6 months

  5. Maternal knowledge on child caring practices

    Maternal knowledge on child caring practices will be assessed using a structured questionnaire.

    Measured: From enrollment to the end of intervention after 6 months.

  6. Maternal depression

    Maternal depressive symptoms will be assessed using the shortened version Centre for Epidemiological Studies-Depression scale

    Measured: From enrollment to the end of intervention after 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2026
  2. Study start1 Aug 2024
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
2,400 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07472699
Sponsor's protocol ID
PR-24109
Acronym
ECD SB3
Status last verified
Dec 2025
First submitted
18 Jan 2026
Last updated
16 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Participants ID, Age, Sex, Socio-economic and demographic information, Treatment group code

Questions about this trial

What is this clinical trial studying?

A study testing Psychosocial stimulation and Combined in people with Early Child Brain Development, run by International Centre for Diarrhoeal Disease Research, Bangladesh at 1 site in Bangladesh.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 16 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Bangladesh. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive development (time frame: From enrollment to the end of intervention after 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in